Helix Biopharma Corp.
HBP.TO
TSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -511.60K | -726.40K | -691.50K | -1.09M | -967.60K |
| Total Depreciation and Amortization | 700.00 | 1.40K | 700.00 | 2.10K | 1.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.90K | 64.90K | 33.50K | 40.80K | 92.20K |
| Change in Net Operating Assets | 168.80K | -220.50K | 184.90K | 71.80K | 212.50K |
| Cash from Operations | -336.20K | -880.60K | -472.40K | -971.60K | -661.50K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -1.40K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 7.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 6.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1.66M | -- | 100.00K | 2.70M |
| Repurchase of Common Stock | -11.00K | -- | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.10K | 1.19M | -700.00 | 70.40K | 1.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -344.30K | 312.00K | -473.10K | -901.30K | 1.24M |